{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T08:55:15Z","timestamp":1765356915456,"version":"build-2065373602"},"reference-count":78,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2021,4,17]],"date-time":"2021-04-17T00:00:00Z","timestamp":1618617600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Cardiovascular implantable electronic devices (CIEDs) are a standard therapy utilized for different cardiac conditions. They are implanted in a growing number of patients, including those with chronic kidney disease (CKD) and end-stage kidney disease (ESKD). Cardiovascular diseases, including heart failure and malignant arrhythmia, remain the leading cause of mortality among CKD patients, especially in ESKD. CIED implantation procedures are considered minor surgery, typically with transvenous leads inserted via upper central veins, followed by an impulse generator introduced subcutaneously. A decision regarding optimal hemodialysis (HD) modality and the choice of permanent vascular access (VA) could be particularly challenging in CIED recipients. The potential consequences of arteriovenous access on the CIED side are related to (1) venous hypertension from lead-related central vein stenosis and (2) the risk of systemic infection. Therefore, when creating permanent vascular access, the clinical scenario may be complicated by the CIED presence on one side and the lack of suitable vessels for arteriovenous fistula on the contralateral arm. These factors suggest the need for an individualized approach according to different clinical situations: (1) CIED in a CKD patient; (2) CIED in a patient on hemodialysis CIED; and (3) VA in a patient with CIED. This complex clinical conundrum creates the necessity for close cooperation between cardiologists and nephrologists.<\/jats:p>","DOI":"10.3390\/jcm10081745","type":"journal-article","created":{"date-parts":[[2021,4,18]],"date-time":"2021-04-18T22:15:13Z","timestamp":1618784113000},"page":"1745","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Cardiac Implantable Electronic Devices in Hemodialysis and Chronic Kidney Disease Patients\u2014An Experience-Based Narrative Review"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9078-0087","authenticated-orcid":false,"given":"Krzysztof","family":"Nowak","sequence":"first","affiliation":[{"name":"Department of Heart Diseases, Wroclaw Medical University, 50-556 Wroclaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6502-0374","authenticated-orcid":false,"given":"Mariusz","family":"Kusztal","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Transplantation Medicine, Wroclaw Medical University, 50-556 Wroclaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,4,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/sdi.12249","article-title":"Cardiovascular Implantable Electronic Devices in Hemodialysis Patients: Prevalence and Implications for Arteriovenous Hemodialysis Access Interventions","volume":"28","author":"Saad","year":"2015","journal-title":"Semin. Dial."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.joa.2017.05.002","article-title":"Long-term survival of implantable cardioverter defibrillator recipients with end-stage renal disease","volume":"33","author":"Matar","year":"2017","journal-title":"J. Arrhythmia"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"A6","DOI":"10.1053\/j.ajkd.2019.09.003","article-title":"US Renal Data System 2019 Annual Data Report: Epidemiology of Kidney Disease in the United States","volume":"75","author":"Saran","year":"2020","journal-title":"Am. J. Kidney Dis."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1093\/eurheartj\/ehy060","article-title":"Chronic kidney disease and arrhythmias: Conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference","volume":"39","author":"Turakhia","year":"2018","journal-title":"Eur. Heart J."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S2213-8587(15)00040-6","article-title":"Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: A collaborative meta-analysis of individual participant data","volume":"3","author":"Matsushita","year":"2015","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e254","DOI":"10.1161\/CIR.0000000000000950","article-title":"Heart disease and stroke statistics-2021 update: A report from the american heart association","volume":"143","author":"Virani","year":"2021","journal-title":"Circulation"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1001\/jamainternmed.2015.6102","article-title":"Representation of patients with kidney disease in trials of cardiovascular interventions: An updated systematic review","volume":"176","author":"Konstantinidis","year":"2016","journal-title":"JAMA Intern. Med."},{"key":"ref_8","first-page":"1220","article-title":"Prevalence and predictor factors of severe venous obstruction after cardiovascular electronic device implantation","volume":"18","author":"Santini","year":"2016","journal-title":"EP Eur."},{"key":"ref_9","first-page":"686","article-title":"Usefulness of preoperative venography in patients with cardiac implantable electronic devices submitted to lead replacement or device upgrade procedures","volume":"111","author":"Albertini","year":"2018","journal-title":"Arq. Bras. Cardiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"83","DOI":"10.17219\/acem\/42317","article-title":"Venous stenosis and occlusion in the presence of endocardial leads","volume":"25","author":"Boczar","year":"2016","journal-title":"Adv. Clin. Exp. Med."},{"key":"ref_11","first-page":"58","article-title":"2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy","volume":"67","author":"Brignole","year":"2014","journal-title":"Rev. Esp. Cardiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/S0085-2538(15)50904-6","article-title":"Survival of dialysis patients after cardiac arrest and the impact of implantable cardioverter defibrillators","volume":"68","author":"Herzog","year":"2005","journal-title":"Kidney Int."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"4199","DOI":"10.19102\/icrm.2020.110803","article-title":"Efficacy of implantable cardioverter-defibrillators for secondary prevention of sudden cardiac death in patients with end-stage renal disease","volume":"11","author":"Payne","year":"2020","journal-title":"J. Innov. Card. Rhythm Manag."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1161\/HYPERTENSIONAHA.110.151167","article-title":"Sudden cardiac death in end-stage renal disease patients: A 5-year prospective analysis","volume":"56","author":"Wang","year":"2010","journal-title":"Hypertension"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/ejhf.592","article-title":"2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"18","author":"Ponikowski","year":"2016","journal-title":"Eur. J. Heart Fail"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1053\/j.ajkd.2013.12.009","article-title":"Implantable cardioverter-defibrillators for primary prevention of sudden cardiac death in CKD: A meta-analysis of patient-level data from 3 randomized trials","volume":"64","author":"Pun","year":"2014","journal-title":"Am. J. Kidney Dis."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/ndt\/gfu274","article-title":"Primary prevention implantable cardioverter defibrillators in end-stage kidney disease patients on dialysis: A matched cohort study","volume":"30","author":"Pun","year":"2015","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.amjcard.2006.03.025","article-title":"Relations among renal function, risk of sudden cardiac death, and benefit of the implanted cardiac defibrillator in patients with ischemic left ventricular dysfunction","volume":"98","author":"Goldenberg","year":"2006","journal-title":"Am. J. Cardiol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1161\/CIRCULATIONAHA.119.039818","article-title":"Prophylactic use of implantable cardioverter-defibrillators in the prevention of sudden cardiac death in dialysis patients","volume":"139","author":"Jukema","year":"2019","journal-title":"Circulation"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ekir.2020.10.020","article-title":"A systematic review of the incidence of arrhythmias in hemodialysis patients undergoing long-term monitoring with implantable loop recorders","volume":"6","author":"Roberts","year":"2020","journal-title":"Kidney Int. Rep."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2174\/1573403X15666190118123754","article-title":"Implantable cardioverter-defibrillators in patients with esrd: Complications, management, and literature review","volume":"15","author":"Mehdi","year":"2019","journal-title":"Curr. Cardiol. Rev."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1159\/000319461","article-title":"Implantable defibrillators improve survival in end-stage renal disease: Results from a multicenter registry","volume":"32","author":"Hiremath","year":"2010","journal-title":"Am. J. Nephrol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.2215\/CJN.11121114","article-title":"Implantable cardioverter-defibrillators in patients with CKD: A propensity-matched mortality analysis","volume":"10","author":"Nakhoul","year":"2015","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s10840-018-0424-1","article-title":"Outcomes of ICDs and CRTs in patients with chronic kidney disease: A meta-analysis of 21,000 patients","volume":"53","author":"Shurrab","year":"2018","journal-title":"J. Interv. Card. Electrophysiol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.2215\/CJN.00620115","article-title":"Cardiac resynchronization therapy in CKD stage 4 patients","volume":"10","author":"Khidir","year":"2015","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1016\/j.jacc.2015.09.097","article-title":"Comparative effectiveness of CRT-D versus defibrillator alone in HF patients with moderate-to-severe chronic kidney disease","volume":"66","author":"Friedman","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ijcard.2006.11.015","article-title":"Prognostic value of renal function in patients with cardiac resynchronization therapy","volume":"122","author":"Fung","year":"2007","journal-title":"Int. J. Cardiol."},{"key":"ref_28","first-page":"2727108","article-title":"Reduced albuminuria and potassemia indicate early renal repair processes after resynchronization therapy in cardiorenal syndrome type 2","volume":"2020","author":"Romanek","year":"2020","journal-title":"Cardiol. Res. Pract."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1053\/j.ajkd.2008.04.026","article-title":"Predicting the risk of dialysis and transplant among patients with CKD: A retrospective cohort study","volume":"52","author":"Johnson","year":"2008","journal-title":"Am. J. Kidney Dis."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1016\/j.kint.2018.01.009","article-title":"Predicting timing of clinical outcomes in patients with chronic kidney disease and severely decreased glomerular filtration rate","volume":"93","author":"Grams","year":"2018","journal-title":"Kidney Int."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1001\/jama.2015.18202","article-title":"Multinational assessment of accuracy of equations for predicting risk of kidney failure: A meta-analysis","volume":"315","author":"Tangri","year":"2016","journal-title":"J. Am. Med. Assoc."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Major, R.W., Shepherd, D., Medcalf, J.F., Xu, G., Gray, L.J., and Brunskill, N.J. (2019). The Kidney Failure Risk Equation for prediction of end stage renal disease in UK primary care: An external validation and clinical impact projection cohort study. PLoS Med., 16, Erratum in 2020, 17, e1003313.","DOI":"10.1371\/journal.pmed.1003313"},{"key":"ref_33","unstructured":"(2021, April 13). Available online: https:\/\/qxmd.com\/calculate\/calculator_308\/kidney-failure-risk-equation-4-variable."},{"key":"ref_34","first-page":"e005706","article-title":"Transvenous lead extraction in chroni\u0107 kidney disease and dialysis patients with infected cardiac devices","volume":"11","author":"Barakat","year":"2018","journal-title":"Circulation"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"F891","DOI":"10.1152\/ajprenal.00163.2014","article-title":"A current understanding of vascular calcification in CKD","volume":"307","author":"Paloian","year":"2014","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3747\/pdi.2017.00180","article-title":"Planning vascular access in peritoneal dialysis-defining high-risk patients","volume":"38","author":"Ferreira","year":"2018","journal-title":"Perit. Dial. Int."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1093\/europace\/euv202","article-title":"Chronic kidney disease in patients with cardiac rhythm disturbances or implantable electrical devices: Clinical significance and implications for decision making-a position paper of the European Heart Rhythm Association endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society","volume":"17","author":"Boriani","year":"2015","journal-title":"Europace"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1023\/B:JICE.0000042354.87946.39","article-title":"Surgical options for endocardial lead placement when upper veins are obstructed or nonusable","volume":"11","author":"Molina","year":"2004","journal-title":"J. Interv. Card. Electrophysiol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1525-139X.2010.00757.x","article-title":"Epicardial cardiac rhythm devices for dialysis patients: Minimizing the risk of infection and preserving central veins","volume":"25","author":"Asif","year":"2012","journal-title":"Semin Dial."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1046\/j.1540-8167.2003.03255.x","article-title":"Left heart pacing lead implantation using subxiphoid videopericardioscopy","volume":"14","author":"Zenati","year":"2003","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1016\/S0735-1097(03)00252-3","article-title":"Robotically assisted left ventricular epicardial lead implantation for biventricular pacing","volume":"41","author":"DeRose","year":"2003","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/pace.13651","article-title":"Implantation of a dual-chamber pacemaker with epicardial leads in adults using a minimally invasive subxyphoid approach","volume":"42","author":"Kempa","year":"2019","journal-title":"Pacing Clin. Electrophysiol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/clc.23300","article-title":"Epicardial left ventricular lead implantation in cardiac resynchronization therapy patients via a video-assisted thoracoscopic technique: Long-term outcome","volume":"43","author":"Marini","year":"2020","journal-title":"Clin. Cardiol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.hrthm.2010.01.014","article-title":"Surgically placed left ventricular leads provide similar outcomes to percutaneous leads in patients with failed coronary sinus lead placement","volume":"7","author":"Ailawadi","year":"2010","journal-title":"Heart Rhythm"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.hrthm.2015.02.023","article-title":"Comparison of delayed transvenous reimplantation and immediate surgical epicardial approach in pacing-dependent patients undergoing extraction of infected permanent pacemakers","volume":"12","author":"Amraoui","year":"2015","journal-title":"Heart Rhythm"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1111\/jce.13661","article-title":"Percutaneous epicardial pacing using a novel transverse sinus device","volume":"29","author":"Vaidya","year":"2018","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.jacep.2016.12.025","article-title":"A novel defibrillation tool: Percutaneously delivered, partially insulated epicardial defibrillation","volume":"3","author":"Killu","year":"2017","journal-title":"JACC Clin. Electrophysiol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1016\/j.athoracsur.2008.02.016","article-title":"A 12-year experience of bipolar steroid-eluting epicardial pacing leads in children","volume":"85","author":"Tomaske","year":"2008","journal-title":"Ann. Thorac. Surg."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"343","DOI":"10.2143\/AC.61.3.2014839","article-title":"Epicardial pacing: A single centre study on 321 leads in 138 patients","volume":"61","author":"Ector","year":"2006","journal-title":"Acta Cardiol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s10840-010-9494-4","article-title":"Epicardial versus endocardial permanent pacing in adults with congenital heart disease","volume":"28","author":"McLeod","year":"2010","journal-title":"J. Interv. Card. Electrophysiol."},{"key":"ref_51","first-page":"42","article-title":"The femoral route revisited: An alternative for pectoral pacing lead implantation","volume":"18","author":"Bracke","year":"2010","journal-title":"Neth. Heart J."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1111\/j.1540-8159.1989.tb01921.x","article-title":"Iliac vein approach to permanent pacemaker implantation","volume":"12","author":"French","year":"1989","journal-title":"Pacing Clin. Electrophysiol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.19102\/icrm.2017.080702","article-title":"Biventricular ICD placement percutaneously via the iliac vein: Case reports and a review","volume":"8","author":"Higgins","year":"2017","journal-title":"J. Innov. Card. Rhythm Manag."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1093\/europace\/eun185","article-title":"Rescue permanent iliac vein pacing after epicardial lead failure: An unusual reversal of pacing fortune","volume":"10","author":"Gupta","year":"2008","journal-title":"Europace"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jacep.2018.12.008","article-title":"Leadless pacemaker implantation in hemodialysis patients: Experience with the micra transcatheter pacemaker","volume":"5","author":"Chami","year":"2019","journal-title":"JACC Clin. Electrophysiol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jacep.2019.10.017","article-title":"Atrioventricular synchronous pacing using a leadless ventricular pacemaker: Results from the MARVEL 2 study","volume":"6","author":"Steinwender","year":"2020","journal-title":"JACC Clin. Electrophysiol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"e190","DOI":"10.1016\/j.hrthm.2017.10.035","article-title":"2017 AHA\/ACC\/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: Executive summary: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society","volume":"15","author":"Stevenson","year":"2018","journal-title":"Heart Rhythm"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.2215\/CJN.07920520","article-title":"Trends in use and in-hospital outcomes of subcutaneous implantable cardioverter defibrillators in patients undergoing long-term dialysis","volume":"15","author":"Pun","year":"2020","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1053\/j.ajkd.2015.01.028","article-title":"Subcutaneous implantable cardioverter defibrillator for dialysis patients: A strategy to reduce central vein stenoses and infections","volume":"66","author":"Dhamija","year":"2015","journal-title":"Am. J. Kidney Dis."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/pace.13314","article-title":"Subcutaneous ICD screening with the Boston Scientific ZOOM programmer versus a 12-lead ECG machine","volume":"41","author":"Chang","year":"2018","journal-title":"Pacing Clin. Electrophysiol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1056\/NEJMoa1915932","article-title":"Subcutaneous or transvenous defibrillator therapy","volume":"383","author":"Knops","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1161\/CIRCULATIONAHA.120.048728","article-title":"Primary results from the understanding outcomes with the S-ICD in primary prevention patients with low ejection fraction (UNTOUCHED) trial","volume":"143","author":"Gold","year":"2021","journal-title":"Circulation"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s10840-015-0093-2","article-title":"Outcomes of subcutaneous implantable cardioverter-defibrillator implantation in patients on hemodialysis","volume":"45","author":"Koman","year":"2016","journal-title":"J. Interv. Card. Electrophysiol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1111\/jce.12705","article-title":"Outcome of subcutaneous implantable cardioverter defibrillator implantation in patients with end-stage renal disease on dialysis","volume":"26","author":"Levy","year":"2015","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"ref_65","unstructured":"(2021, April 13). Available online: https:\/\/www.fda.gov\/medical-devices\/medical-device-recalls\/boston-scientific-corporation-recalls-emblem-s-icd-subcutaneous-implantable-cardioverter."},{"key":"ref_66","unstructured":"(2021, April 13). Available online: https:\/\/www.fda.gov\/medical-devices\/medical-device-recalls\/boston-scientific-recalls-emblem-s-icd-subcutaneous-electrode-model-3501-due-risk-fractures."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1093\/europace\/eut124","article-title":"First-in-man implantation of leadless ultrasound-based cardiac stimulation pacing system: Novel endocardial left ventricular resynchronization therapy in heart failure patients","volume":"15","author":"Auricchio","year":"2013","journal-title":"Europace"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/j.hrthm.2020.03.002","article-title":"Real-world experience of leadless left ventricular endocardial cardiac resynchronization therapy: A multicenter international registry of the WiSE-CRT pacing system","volume":"17","author":"Sieniewicz","year":"2020","journal-title":"Heart Rhythm"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1111\/pace.13750","article-title":"First-in-man fully leadless transvenous CRT-P with a transseptal implant of WISE-CRT\u00ae system and Micra\u00ae PM","volume":"42","author":"Montemerlo","year":"2019","journal-title":"Pacing Clin. Electrophysiol."},{"key":"ref_70","first-page":"euaa342","article-title":"European experience with a first totally leadless cardiac resynchronization therapy pacemaker system","volume":"13","author":"Carabelli","year":"2020","journal-title":"Europace"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1007\/s10016-003-0048-4","article-title":"Symptomatic subclavian vein stenosis and occlusion in hemodialysis patients with transvenous pacemakers","volume":"17","author":"Teruya","year":"2003","journal-title":"Ann. Vasc. Surg."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.avsg.2018.10.003","article-title":"Arteriovenous fistula and graft construction in patients with implantable cardiac devices: Does side matter?","volume":"54","author":"Sgroi","year":"2019","journal-title":"Ann. Vasc. Surg."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Jeong, S., Nam, G.B., Chang, J.W., Kim, M.J., Han, Y., Kwon, T.W., and Cho, Y.P. (2018). Impact of transvenous cardiac implantable electronic devices in chronic hemodialysis patients: A single-center, observational comparative study. BMC Nephrol., 19.","DOI":"10.1186\/s12882-018-1095-y"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/sdi.12581","article-title":"Venous hemodialysis catheters and cardiac implantable electronic devices: Avoiding a high-risk combination","volume":"30","author":"Saad","year":"2017","journal-title":"Semin. Dial."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1053\/j.ajkd.2013.11.018","article-title":"Clinical presentation and outcomes of cardiovascular implantable electronic device infections in hemodialysis patients","volume":"64","author":"Hickson","year":"2014","journal-title":"Am. J. Kidney Dis."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1016\/j.hrthm.2015.08.003","article-title":"Cardiac implantable electronic device infection in patients with end-stage renal disease","volume":"12","author":"Guha","year":"2015","journal-title":"Heart Rhythm"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/j.1525-139X.2012.01053.x","article-title":"Transvenous cardiac implantable electronic devices and hemodialysis catheters: Recommendations to curtail a potentially lethal combination","volume":"25","author":"Asif","year":"2012","journal-title":"Semin. Dial."},{"key":"ref_78","first-page":"1527","article-title":"Outcomes of lead extraction without subsequent device reimplantation","volume":"19","author":"Killu","year":"2017","journal-title":"Europace"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/10\/8\/1745\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:49:10Z","timestamp":1760161750000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/10\/8\/1745"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,17]]},"references-count":78,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2021,4]]}},"alternative-id":["jcm10081745"],"URL":"https:\/\/doi.org\/10.3390\/jcm10081745","relation":{},"ISSN":["2077-0383"],"issn-type":[{"type":"electronic","value":"2077-0383"}],"subject":[],"published":{"date-parts":[[2021,4,17]]}}}